TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21510886

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment
Number of subjects: 401

Group type: COMPARATOR
Intervention: Traditional care in an orthopaedic ward
Number of subjects: 401
Study: 18291049

Group type: EXPERIMENTAL
Intervention: Dräger Evita XL
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Maquet Servo‐i
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Newport e500
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Puritan Bennett 840
Number of subjects: 21

Group type: COMPARATOR
Intervention: All ventilators
Number of subjects: 21
Study: 16933235

Group type: EXPERIMENTAL
Intervention: HCV-Ab(XTL)68 120 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: HCV-Ab(XTL)68 240 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All active treatments combined
Number of subjects: 24
Study: 15309392

Group type: EXPERIMENTAL
Intervention: Citalopram treatment (initial dose of 20mg, with increments to a maximum of 60 mg over 8 weeks)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Citalopram treatment
Number of subjects: 39

Group type: COMPARATOR
Intervention: Healthy controls (no treatment)
Number of subjects: 39
Study: 11401871

Group type: EXPERIMENTAL
Intervention: PC(20) adenosine 5'-monophosphate (AMP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: PC(20) methacholine
Number of subjects: 120
Study: 9406266

Group type: EXPERIMENTAL
Intervention: Standard-dose olanzapine (5 to 15 mg a day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ineffective-dose olanzapine (1 mg a day)
Number of subjects: 120
Study: 8221219

Group type: EXPERIMENTAL
Intervention: Experimental group (participated in the sexual abuse prevention program)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Pretest authority scores
Number of subjects: 117
Study: 3312603

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 30199288

Group type: EXPERIMENTAL
Intervention: Participation in CACFP
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Child care centers
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: New CACFP standards
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Timing of introduction of solids, serving sweet grains, serving yogurt low in sugar, serving appropriate milk types
Number of subjects: 680
Study: 28253050

Group type: EXPERIMENTAL
Intervention: Walking plus exclusion feedback
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Walking plus neutral feedback
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sedentary plus exclusion feedback
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sedentary plus neutral feedback
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sedentary prior to exclusion
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 96
Study: 26198433

Group type: EXPERIMENTAL
Intervention: Interprofessional Medication Therapy Management (MTM) approach
Number of subjects: 165
Study: 23916488

Group type: EXPERIMENTAL
Intervention: Bevacizumab (1.25 mg)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Ranibizumab (0.50 mg)
Number of subjects: 501
Study: 20233526

Group type: EXPERIMENTAL
Intervention: Ningdong (ND) granule, 1 g/kg per day, n = 33
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo, n = 31
Number of subjects: 64
Study: 18550156

Group type: EXPERIMENTAL
Intervention: HT008-1
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 16809911

Group type: EXPERIMENTAL
Intervention: GLP-1 infusion (1.5 pmol/kg x min)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 17
Study: 12672313

Group type: EXPERIMENTAL
Intervention: Nutrient-enriched diet
Number of subjects: 216

Group type: COMPARATOR
Intervention: Lower-nutrient diet
Number of subjects: 216

Group type: COMPARATOR
Intervention: Reference group (born at term)
Number of subjects: 216
Study: 10664518

Group type: COMPARATOR
Intervention: Methimazole alone (group 1, n=44)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Methimazole + T3 (group 2, n=39)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: T3 alone (group 3, n=31)
Number of subjects: 135
Study: 8872973

Group type: EXPERIMENTAL
Intervention: ACEI withdrawal (enalapril or captopril replaced by nifedipine or clonidine)
Number of subjects: 15

Group type: COMPARATOR
Intervention: ACEI (enalapril or captopril)
Number of subjects: 15
Study: 1524606

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oxazepam
Number of subjects: 60
Study: 6479685

Group type: EXPERIMENTAL
Intervention: Celestin technique
Number of subjects: 72

Group type: COMPARATOR
Intervention: Eder-Puestow technique
Number of subjects: 72
Study: 30626287

Group type: EXPERIMENTAL
Intervention: 4×40 stent retriever
Number of subjects: 715

Group type: COMPARATOR
Intervention: 4×20 stent retriever
Number of subjects: 715

Group type: COMPARATOR
Intervention: 6×30 stent retriever
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: All stent retriever sizes
Number of subjects: 715
Study: 30185111

Group type: EXPERIMENTAL
Intervention: Blocked practice
Number of subjects: 52

Group type: COMPARATOR
Intervention: Random practice
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both practice groups
Number of subjects: 52
Study: 27174641

Group type: EXPERIMENTAL
Intervention: Family partnership intervention (FPI)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Patient and family education (PFE)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 117
Study: 25078900

Group type: EXPERIMENTAL
Intervention: Gla‐300 (insulin glargine 300 units/mL)
Number of subjects: 807

Group type: COMPARATOR
Intervention: Gla‐100 (insulin glargine 100 units/mL)
Number of subjects: 807
Study: 21807480

Group type: EXPERIMENTAL
Intervention: PS-Omega3
Number of subjects: 200

Group type: COMPARATOR
Intervention: PS-Omega3 (after switching from placebo)
Number of subjects: 200
Study: 20106943

Group type: EXPERIMENTAL
Intervention: Glatiramer Acetate (GA) therapy
Number of subjects: 232
Study: 17555412

Group type: EXPERIMENTAL
Intervention: Curettes (H-group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (L-group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Sonic device (S-group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ultrasonic device (U-group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ultrasonic treatment
Number of subjects: 72
Study: 16298722

Group type: EXPERIMENTAL
Intervention: CBT+EX
Number of subjects: 217

Group type: COMPARATOR
Intervention: CBT
Number of subjects: 217
Study: 12224568

Group type: EXPERIMENTAL
Intervention: Parasight-F test
Number of subjects: 143
Study: 10193874

Group type: EXPERIMENTAL
Intervention: High protein and carbohydrate diet (HP/C)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High fat diet (HF)
Number of subjects: 8
Study: 8851647

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard neuroleptic therapy
Number of subjects: 0
Study: 2076683

Group type: EXPERIMENTAL
Intervention: Manual vacuum aspiration (MVA)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Sharp curettage (control)
Number of subjects: 300
Study: 375147

Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Abdominal hysterectomy (Penicillin or Cefazolin)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 317
Study: 31033232

Group type: EXPERIMENTAL
Intervention: Group-based outpatient physical therapy (PT) intervention (6 sessions)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 180
Study: 30871514

Group type: EXPERIMENTAL
Intervention: Green cardamom (GC) supplementation, 500 mg capsules, 3 times/day for 3 months
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 28986058

Group type: EXPERIMENTAL
Intervention: Polypill group
Number of subjects: 3140
Study: 26404640

Group type: EXPERIMENTAL
Intervention: Op Volle Kracht (OVK) intervention group, n=655
Number of subjects: 1341

Group type: COMPARATOR
Intervention: Control group (school as usual), n=735
Number of subjects: 1341
Study: 22907065

Group type: EXPERIMENTAL
Intervention: Customized thoracolumbosacral orthosis (TLSO)
Number of subjects: 23

Group type: COMPARATOR
Intervention: No-brace
Number of subjects: 23
Study: 23084675

Group type: EXPERIMENTAL
Intervention: LUAL + ISM
Number of subjects: 144

Group type: COMPARATOR
Intervention: ISM
Number of subjects: 144
Study: 19934131

Group type: EXPERIMENTAL
Intervention: Clinical features (age, duration of symptoms, sex, radiation of pain to the right arm)
Number of subjects: 1576

Group type: EXPERIMENTAL
Intervention: Troponin measurement, creatine kinase MB(mass) gradient, treadmill exercise testing
Number of subjects: 1576
Study: 17514399

Group type: EXPERIMENTAL
Intervention: Pneumatic dilatation to a diameter of 30-40 mm
Number of subjects: 51

Group type: COMPARATOR
Intervention: Laparoscopic myotomy with posterior partial fundoplication
Number of subjects: 51

Group type: COMPARATOR
Intervention: Laparoscopic myotomy
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Pneumatic dilatation
Number of subjects: 51
Study: 15140342

Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg once daily for 10 days
Number of subjects: 448

Group type: COMPARATOR
Intervention: Clarithromycin 500 mg twice daily for 10 days
Number of subjects: 448
Study: 12198820

Group type: EXPERIMENTAL
Intervention: Various drugs evaluated in RCTs since the 1970s for diabetic neuropathy treatment.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drugs for diabetic neuropathy treatment.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adequate designs for RCTs in diabetic neuropathy.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term trials (3-5 years) focusing on patients with mild or moderate early stages of neuropathy.
Number of subjects: 0
Study: 9932558

Group type: EXPERIMENTAL
Intervention: Motivational interviewing videotape training
Number of subjects: 30

Group type: COMPARATOR
Intervention: 20-minute docudrama of a pregnant problem drinker
Number of subjects: 30
Study: 8848940

Group type: EXPERIMENTAL
Intervention: H-reflex latency of the flexor carpi radial muscle (HFCR)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: EMG (needle myography and bilateral determination of HFCR)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: EMG
Number of subjects: 68
Study: 2172280

Group type: EXPERIMENTAL
Intervention: RU 486 (10 mg/kg.day) for 7-14 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo vehicle
Number of subjects: 11
Study: 910457

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid sutures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Catgut sutures
Number of subjects: 0
Study: 31858673

Group type: EXPERIMENTAL
Intervention: Insulin degludec/liraglutide (IDegLira)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin degludec or insulin glargine U100
Number of subjects: 0
Study: 30741744

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg/day)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Rosuvastatin (40 mg/day)
Number of subjects: 106
Study: 26808701

Group type: EXPERIMENTAL
Intervention: 400‐μm microkeratome head
Number of subjects: 20

Group type: COMPARATOR
Intervention: 350‐μm microkeratome head
Number of subjects: 20
Study: 26225282

Group type: EXPERIMENTAL
Intervention: Transforaminal lumbar interbody fusion (TLIF)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Uninstrumented posterolateral fusion (PLF)
Number of subjects: 135
Study: 23939296

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 28

Group type: COMPARATOR
Intervention: F-LASIK
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: SMILE and F-LASIK
Number of subjects: 28
Study: 22029979

Group type: EXPERIMENTAL
Intervention: qHPV vaccine
Number of subjects: 602

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 602
Study: 18779948

Group type: EXPERIMENTAL
Intervention: Applicator used for femoral component insertion
Number of subjects: 124

Group type: COMPARATOR
Intervention: No applicator used for femoral component insertion
Number of subjects: 124
Study: 15911951

Group type: EXPERIMENTAL
Intervention: Nebulised lidocaine
Number of subjects: 127

Group type: COMPARATOR
Intervention: Nebulised bronchodilator (terbutaline)
Number of subjects: 127
Study: 10670125

Group type: EXPERIMENTAL
Intervention: BCG 27 mg weekly x 6 and monthly until complete one year (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: BCG plus Tegafur 800 mg daily until complete one year (Group B)
Number of subjects: 80
Study: 8601654

Group type: EXPERIMENTAL
Intervention: 40% trichloroacetic acid (TCA) chemical peel with topical tretinoin pretreated for 6 weeks and used after the peel
Number of subjects: 16

Group type: COMPARATOR
Intervention: 40% trichloroacetic acid (TCA) chemical peel alone
Number of subjects: 16
Study: 2021877

Group type: EXPERIMENTAL
Intervention: Acarosan treatment group (cleaning + benzylbenzoate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intensive cleaning without acaricidal treatment
Number of subjects: 20
Study: 6805019

Group type: EXPERIMENTAL
Intervention: Sedative-hypnotics (Benzodiazepine hypnotics)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 31337047

Group type: EXPERIMENTAL
Intervention: NASA Mission X (MX) Program delivered by nutritional experts and class teachers over 10 weeks
Number of subjects: 534

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 534
Study: 29576202

Group type: EXPERIMENTAL
Intervention: Island cartilage graft
Number of subjects: 70

Group type: COMPARATOR
Intervention: Temporalis fascia graft
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 70
Study: 26864362

Group type: EXPERIMENTAL
Intervention: Higher protein intake (20% protein)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Higher protein intake (30% protein)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: High-protein diet (1.5 g · kg(‐1) · d(‐1))
Number of subjects: 44

Group type: COMPARATOR
Intervention: Normal-protein diet (0.8 g · kg(‐1) · d(‐1))
Number of subjects: 44
Study: 24440105

Group type: EXPERIMENTAL
Intervention: 45-degree aperture angled tip (Group 1)
Number of subjects: 2

Group type: COMPARATOR
Intervention: 30-degree aperture angled tip (Group 2)
Number of subjects: 2
Study: 22555398

Group type: EXPERIMENTAL
Intervention: Gemcitabine and S-1 combination therapy
Number of subjects: 106

Group type: COMPARATOR
Intervention: Gemcitabine alone
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 106
Study: 19170225

Group type: EXPERIMENTAL
Intervention: Epoetin-alpha initiated immediately (early intervention)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Epoetin-alpha initiated when hemoglobin decreased to <11 g/dL (standard intervention)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Epoetin-alpha initiated immediately (nonrandomized group)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Epoetin-alpha (all groups)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Epoetin-alpha (early intervention)
Number of subjects: 186
Study: 17383620

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 0
Study: 15209199

Group type: EXPERIMENTAL
Intervention: Physician practice styles emphasizing technically oriented activities and health behavior discussions
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Self-reported pain measured with the Visual Analog Pain Scale
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Self-reported pain measured with the Medical Outcomes Study Short Form-36
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Female patients reporting pain
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Physician recognition of patient pain
Number of subjects: 509
Study: 12133465

Group type: EXPERIMENTAL
Intervention: H(2) vaccine
Number of subjects: 457251

Group type: EXPERIMENTAL
Intervention: LA-1 vaccine
Number of subjects: 457251

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 457251

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 457251
Study: 9820211

Group type: EXPERIMENTAL
Intervention: Biojector 2000 (jet injector)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Syringe and needle (midazolam)
Number of subjects: 14
Study: 7710799

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 40

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 40
Study: 30169657

Group type: EXPERIMENTAL
Intervention: Genome-wide association study (GWAS) for SCA
Number of subjects: 3939

Group type: EXPERIMENTAL
Intervention: Candidate arrhythmia genes
Number of subjects: 3939

Group type: EXPERIMENTAL
Intervention: Cross-trait multi-variant genetic risk score associations (GRSA)
Number of subjects: 3939
Study: 28095904

Group type: EXPERIMENTAL
Intervention: Community mobilization (CM) intervention conducted in 8 intervention communities over 3 years.
Number of subjects: 30000

Group type: COMPARATOR
Intervention: Control communities (7 communities) with no CM intervention.
Number of subjects: 30000
Study: 26668435

Group type: EXPERIMENTAL
Intervention: Youth Readiness Intervention (cognitive-behavioral intervention)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 436
Study: 24282872

Group type: EXPERIMENTAL
Intervention: New calcium carbonate toothpaste with 0.3% triclosan and magnesium aluminium silicate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Marketed calcium carbonate toothpaste with 0.3% triclosan
Number of subjects: 0
Study: 20872359

Group type: EXPERIMENTAL
Intervention: 0.5% carboxymethylcellulose and 0.9% glycerin (CMCs) administered QID
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.2% sodium hyaluronate (SH) administered QID
Number of subjects: 20
Study: 18649044

Group type: EXPERIMENTAL
Intervention: Active LLLT (830 nm wavelength, 100 mW output, spot size 0.0028 cm(2), 200 s total irradiation time)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo LLLT
Number of subjects: 10
Study: 17845919

Group type: EXPERIMENTAL
Intervention: Echocardiography performed
Number of subjects: 569

Group type: COMPARATOR
Intervention: No echocardiography performed
Number of subjects: 569
Study: 15248821

Group type: EXPERIMENTAL
Intervention: Sodium selenite (500 microg/day for the first 3 days, reducing to 250 and then 125 microg/day every 3 days)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Sodium selenite
Number of subjects: 41
Study: 11459079

Group type: EXPERIMENTAL
Intervention: Famotidine 2 mg/kg/day (maximum 100 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 9758390

Group type: EXPERIMENTAL
Intervention: EEG recorded during memorization of concrete and abstract nouns
Number of subjects: 16
Study: 7920221

Group type: EXPERIMENTAL
Intervention: Intravenous methotrexate (MTX) 5 g/m2 as a 24 hour-infusion
Number of subjects: 114
Study: 3393193

Group type: EXPERIMENTAL
Intervention: Indwelling catheters placed during the operation and removed the next morning
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intermittent catheterization as needed
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 31172324

Group type: COMPARATOR
Intervention: 2D vision system
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 3D vision system
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both 2D and 3D vision systems
Number of subjects: 51
Study: 30483707

Group type: EXPERIMENTAL
Intervention: Revascularization treatment
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Continuing dental education
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Interest in revascularization
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Unfamiliarity with operational procedure
Number of subjects: 834
Study: 28834326

Group type: EXPERIMENTAL
Intervention: Clinician live assessment
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Patient self-assessment
Number of subjects: 385

Group type: COMPARATOR
Intervention: BCCT.core assessment
Number of subjects: 385

Group type: COMPARATOR
Intervention: Panel assessment of photographs
Number of subjects: 385

Group type: COMPARATOR
Intervention: pBRA measurements
Number of subjects: 385
Study: 26632893

Group type: EXPERIMENTAL
Intervention: Reverse hybrid therapy (pantoprazole plus amoxicillin for 12 days and clarithromycin plus metronidazole for the initial 7 days)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Standard triple therapy (pantoprazole plus amoxicillin and clarithromycin for 12 days)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Reverse hybrid therapy
Number of subjects: 440

Group type: COMPARATOR
Intervention: Standard triple therapy
Number of subjects: 440
Study: 23127191

Group type: EXPERIMENTAL
Intervention: Relaxation and visualization combined with structured attentive behavior
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Fentanyl analgesics
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control group (conventional care and treatment)
Number of subjects: 147
Study: 21045648

Group type: EXPERIMENTAL
Intervention: Omega-3 supplement (daily dose of fish oil: 450 mg eicosapentaenoic acid, 300 mg docosahexaenoic acid, 1000 mg flaxseed oil) for 90 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Omega-3 supplement
Number of subjects: 36
Study: 18319224

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate spray
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 45
Study: 16784009

Group type: EXPERIMENTAL
Intervention: 75000 standardized quality tablet (SQ-T) units
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 12488949

Group type: EXPERIMENTAL
Intervention: Low glycaemic index (GI) breakfast
Number of subjects: 0

Group type: COMPARATOR
Intervention: High glycaemic index (GI) breakfast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low glycaemic index (GI) diet for rats
Number of subjects: 0

Group type: COMPARATOR
Intervention: High glycaemic index (GI) diet for rats
Number of subjects: 0